Cargando…
Triple kill: DDR inhibitors, radiotherapy and immunotherapy leave cancer cells with no escape: DDR inhibitors, radiotherapy and immunotherapy can kill cancer cells
Radiotherapy (RT) has been widely used in the clinical treatment of cancers, but radiotherapy resistance (RR) leads to RT failure, tumor recurrence and metastasis. Many studies have been performed on the potential mechanisms behind RR, and a strong link has been found between RR and DNA damage. RT-i...
Autores principales: | Qiu, Yuyue, Hu, Xinru, Zeng, Xiaoping, Wang, Hongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828448/ https://www.ncbi.nlm.nih.gov/pubmed/36305726 http://dx.doi.org/10.3724/abbs.2022153 |
Ejemplares similares
-
DDR1 key for cancer cell escape
por: Leslie, Mitch
Publicado: (2014) -
Characterization of DDR2 Inhibitors for the Treatment
of DDR2 Mutated Nonsmall Cell Lung Cancer
por: Terai, Hideki, et al.
Publicado: (2015) -
The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
por: Elkamhawy, Ahmed, et al.
Publicado: (2021) -
Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
por: Denny, William A., et al.
Publicado: (2021) -
Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy
por: Tu, Megan M., et al.
Publicado: (2019)